Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15905 | 616 | 41.1 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ENDOTHELIUM DEPENDENT CONTRACTIONS | Author keyword | 34 | 93% | 2% | 13 |
2 | ENDOTHELIUM DEPENDENT CONTRACTION | Author keyword | 21 | 65% | 3% | 20 |
3 | ENDOTHELIUM DERIVED CONTRACTING FACTOR | Author keyword | 14 | 40% | 4% | 27 |
4 | ENDOTHELIUM DERIVED CONTRACTING FACTORS | Author keyword | 10 | 52% | 2% | 13 |
5 | PROSTAGLANDIN H 2 | Author keyword | 5 | 34% | 2% | 12 |
6 | DIABETE MALAD METAB | Address | 4 | 75% | 0% | 3 |
7 | PROSTAGLANDIN ENDOPEROXIDES | Author keyword | 4 | 56% | 1% | 5 |
8 | TP RECEPTORS | Author keyword | 4 | 33% | 1% | 9 |
9 | THROMBOXANE PROSTANOID RECEPTOR | Author keyword | 2 | 38% | 1% | 5 |
10 | REACTIVITY OF RAT AORTA | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SHR AORTA | 29 | 73% | 4% | 22 |
2 | DEPENDENT CONTRACTIONS | 19 | 35% | 7% | 45 |
3 | ENDOTHELIUM DEPENDENT CONTRACTIONS | 18 | 33% | 7% | 44 |
4 | CONTRACTING FACTOR | 7 | 37% | 3% | 16 |
5 | PROSTAGLANDIN H 2 | 5 | 40% | 2% | 10 |
6 | MOUSE ARTERIES | 4 | 67% | 1% | 4 |
7 | VASOCONSTRICTOR PROSTANOIDS | 3 | 50% | 1% | 4 |
8 | PROSTAGLANDIN H2 | 3 | 26% | 1% | 9 |
9 | SALT INDUCED HYPERTENSION | 2 | 14% | 3% | 16 |
10 | CONSTRICTING FACTOR | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Endothelium-mediated control of vascular tone: COX-1 and COX-2 products | 2011 | 59 | 189 | 24% |
Endothelium-Dependent Contractions in Hypertension When Prostacyclin Becomes Ugly | 2011 | 21 | 94 | 52% |
Endothelium-dependent contractions: when a good guy turns bad! | 2008 | 53 | 103 | 53% |
Endothelium-dependent contractions in hypertension | 2005 | 151 | 78 | 35% |
Endothelial dysfunction and vascular disease | 2009 | 269 | 414 | 18% |
COX-mediated endothelium-dependent contractions: from the past to recent discoveries | 2010 | 29 | 93 | 45% |
Vasoconstrictor prostanoids | 2010 | 30 | 96 | 43% |
Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors | 2009 | 52 | 118 | 49% |
Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions | 2009 | 36 | 91 | 53% |
New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension | 2014 | 8 | 148 | 16% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIABETE MALAD METAB | 4 | 75% | 0.5% | 3 |
2 | CLIN ATHEROSCLEROSIS | 1 | 38% | 0.5% | 3 |
3 | JIANGSU PROVINCE HOSP | 1 | 38% | 0.5% | 3 |
4 | EXCELLENCE EXAMINAT REGULATORY ROLE NITR OXID | 1 | 24% | 0.6% | 4 |
5 | DIABET MALAD METAB | 1 | 30% | 0.5% | 3 |
6 | CITY CLIN HOSP 15 | 1 | 50% | 0.2% | 1 |
7 | CLIN PHARMACOL CRUCIFORM PROJECT | 1 | 50% | 0.2% | 1 |
8 | DIABET MALADIES METAB | 1 | 50% | 0.2% | 1 |
9 | EXPTL THER EUT 1 BAYLOR PLAZA ROOM 802E | 1 | 50% | 0.2% | 1 |
10 | HOECHST MAR ROUSSEL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000269123 | EDRF//NG NITRO L ARGININE//EDRF ENDOTHELIUM DERIVED RELAXING FACTOR |
2 | 0.0000181841 | NA DEPENDENT CA2 UPTAKE//TISSUE INHIBITOR OF METALLOPROTEASE 2//PULMONARY ARTERY SMOOTH MUSCLE |
3 | 0.0000170462 | ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR//EDHF//ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR EDHF |
4 | 0.0000162528 | NITRERGIC INNERVATION//INCREASED FLOW//MALE SEX HORMONES |
5 | 0.0000155677 | VASCULAR AGING//REYNOLDS OKLAHOMA AGING//ENDOTHELIUM DEPENDENT DILATION |
6 | 0.0000146777 | NORMAL PATHOL PHYSIOL//NO DEFICIENCY//L NAME HYPERTENSION |
7 | 0.0000146615 | PHYSIOL MORPHOL//RAT AORTAE//CHARLIE NORWOOD VET ADM MED |
8 | 0.0000137145 | GI ALPHA PROTEINS//GI ALPHA PROTEIN//GQALPHA PROTEIN |
9 | 0.0000128667 | STRUCTURAL VASCULAR CHANGES//SMOOTH MUSCLE PROGRAMME//VASCULAR HYPERTROPHY |
10 | 0.0000111591 | FLOW MEDIATED DILATION//FLOW MEDIATED DILATATION//ENDOTHELIAL FUNCTION |